Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
121.89
+0.82 (+0.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Just Say No to Drugs: 3 Pharma Stocks to Avoid
Today 10:30 EDT
Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.
Via
InvestorPlace
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
Today 9:01 EDT
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:MRK),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:AZN) EQNX::TICKER_END
Via
FinancialNewsMedia
Check Out What Whales Are Doing With MRNA
May 07, 2024
Via
Benzinga
Moderna's Options Frenzy: What You Need to Know
May 06, 2024
Via
Benzinga
Navigating 6 Analyst Ratings For Moderna
May 03, 2024
Via
Benzinga
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
May 02, 2024
Via
ACCESSWIRE
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,100 Today
May 01, 2024
Via
Benzinga
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
Today 8:30 EDT
From
FN Media Group LLC
Via
GlobeNewswire
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
May 06, 2024
After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report
Via
MarketBeat
Exposures
COVID-19
Smart Money Is Betting Big In MRNA Options
April 30, 2024
Via
Benzinga
Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
May 05, 2024
Last week's top performers included Carvana, Pinterest, Moderna and JD.Com.
Via
Benzinga
MSFT Analysis: Why Microsoft Stock Is a Must-Own for Investors in 2024
May 04, 2024
Microsoft's cloud unit growing very rapidly and gaining market share. Coupled with a visionary CEO, Microsoft stock is a buy.
Via
InvestorPlace
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
May 03, 2024
Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns.
Via
InvestorPlace
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
May 03, 2024
Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.
Via
InvestorPlace
Why Moderna Stock Blasted 13% Higher Today
May 02, 2024
The company notched beats on both the top and bottom lines despite a major drop-off in demand for its famous product.
Via
The Motley Fool
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?
May 02, 2024
U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
10 Health Care Stocks Whale Activity In Today's Session
May 02, 2024
Via
Benzinga
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
May 02, 2024
Moderna reports Q1 loss, beating sales estimates amidst declining COVID-19 vaccine demand. Cost-saving measures drive optimism for investors. CEO Stéphane Bancel eyes strategic investments. Guidance...
Via
Benzinga
Exposures
COVID-19
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
May 02, 2024
After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just reported encouraging data from its Phase III gastric cancer treatment trial after...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Moderna (MRNA) Q1 2024 Earnings Call Transcript
May 02, 2024
MRNA earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
MRNA stock results show that Moderna beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
May 02, 2024
Via
Benzinga
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
May 02, 2024
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
May 02, 2024
Moderna is forming its first base in over a year. Could shares top a buy point on the company's sales beat?
Via
Investor's Business Daily
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cathie Wood Stocks
May 02, 2024
Current economic tides have turned against Cathie Wood's style of aggressive investing, with three of her picks in particular danger.
Via
InvestorPlace
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
May 01, 2024
These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.
Via
InvestorPlace
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
April 30, 2024
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.
Via
InvestorPlace
mRNA Is Promising A Breakthrough In Fighting Cancer
April 29, 2024
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it...
Via
Benzinga
Exposures
COVID-19
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
April 29, 2024
These stocks aren't bargains.
Via
The Motley Fool
Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now
April 29, 2024
Many technology stocks are soaring, and you may be wondering if they've gotten too expensive.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.